Article
Guggenheim Maintains Buy on Claritev, Lowers Price Target to $38
Guggenheim analyst Jason Cassorla maintains Claritev (NYSE:CTEV) with a Buy and lowers the price target from $43 to $38.
Comments
- No comments yet. Be the first to comment!